Molecular mechanisms: Autism protein forms aggregates
DISC1, an autism-associated protein, can form large aggregates that deplete the amount of functional DISC1 in cells, according to a study published 14 February in Human Molecular Genetics.
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
DISC1, an autism-associated protein, can form large aggregates that deplete the amount of functional DISC1 in cells, according to a study published 14 February in Human Molecular Genetics.
A new clinical trial, conducted entirely online, could provide a model for how to quickly and efficiently test some potential treatments for autism.
Minority children tend to show more severe symptoms of autism early on, regardless of social class.
The French documentary Le Mur (The Wall) shows that many psychoanalysts in France shun biological explanations for autism.
A new meta-analysis shows that less than two percent of participants in studies of behavioral interventions for autism are adults.
Researchers have identified a new mechanism that may underlie a runaway cell signaling pathway in fragile X syndrome. The results were published 22 January in Nature Neuroscience.
Brain imaging studies of people with autism show that specific areas respond more strongly to song than do those of controls. The opposite is true when listening to speech.
Engineers have debuted several new robots to help children with autism, including a boy that can sense when it’s touched, a female head that expresses a wide range of emotions and a low-cost fuzzy penguin that can track a child’s eye movements.
Brain imaging can detect acute sensitivity to sound in individuals with autism, according to a study published 25 January in Neurophysiology.
Simulating neuronal development in culture with cells derived from human brain tissue offers a new way to study the function of autism-linked genes, according to research published in the February issue of Molecular Psychiatry.